Highest-materiality recent filing
TruBridge acquired by IKS Health for $26.25/share; merger completed July 9, 2026
Shareholders received $26.25 per share in cash; stock ceased trading on Nasdaq.
TruBridge shareholders approve merger with Inventurus; closing expected July 9, 2026
Merger proposal approved with 11,305,399 votes for, 8,818 against, 19,927 abstaining.
TruBridge: HSR waiting period expires for merger with Inventurus Knowledge Solutions
HSR Act waiting period expired June 22, 2026, clearing one condition for the pending merger with Inventurus Knowledge Solutions.
TruBridge to be acquired by IKS Health for $26.25/share in cash
Per share cash consideration of $26.25; support agreements cover ~27% of outstanding TruBridge common stock.
TruBridge Q4 revenue $87.2M, full-year GAAP net income $4.4M; engages strategic review
Q4 revenue $87.2M (down 1% YoY); bookings $19.8M (+38% YoY); recurring revenue 94%.
TruBridge appoints Pinetree President Damien Leonard to board; three directors to retire by 2027
Damien Leonard (Pinetree President) joins TruBridge Board Jan 12; board expands to 10, then shrinks to 7 after 2026 annual meeting.
Revolver capacity increased to $180M (from $160M); term loan outstanding now $70M (up from $54M).
TruBridge Q3 2025: Revenue $86.1M, GAAP net income $5.6M, Adj EBITDA $16.3M, raises guidance
Total revenue $86.1M, up 1.7% YoY; recurring revenue 94% of total; Financial Health segment $54.5M (63% of revenue).
TruBridge: CSO Dawn Severance to depart Oct 31; Michael Daughton hired as Chief Business Officer
CSO Dawn Severance will leave Oct 31, 2025; position eliminated; no disagreement cited.
Total revenue $85.7M flat YoY; recurring revenue 95%. Financial Health segment $54.3M.
TruBridge dismisses Grant Thornton, appoints KPMG; prior adverse internal control opinions
Audit Committee dismissed Grant Thornton LLP as auditor, effective June 25, 2025.
TruBridge Q1 beats with $87.2M revenue & $18.2M adj. EBITDA; raises FY outlook
Revenue of $87.2M grew 3.7% YoY; GAAP net income $0.5M vs. $1.9M loss; non-GAAP net income $5.2M vs. $3.4M.
TruBridge reports FY2024 revenue $339.2M, net loss $23.1M; issues FY2025 guidance
Q4 2024 revenue $87.4M (up 1.7% YoY); adjusted EBITDA $17.2M vs $12.0M YoY.
TruBridge adds two directors, declassifies board in cooperation deal with top investors
Appointed Jerry Canada (former Group President, Harris Computer Healthcare) and Dris Upitis (Head of Ocho) as independent Class II directors, increasing board from 7 to 9.
TruBridge Q3 revenue $83.8M, bookings $21M; COO David Dye retiring
Q3 revenue $83.8M vs $82.7M YoY; bookings $21.0M (up 40% from $15.0M).
TruBridge Q2 revenue flat at $84.7M, adjusted EBITDA up to $12.6M, reaffirms FY guidance
Total revenue $84.7M vs $84.6M; RCM revenue grew 13% to $54.1M (63.9% of total).
TruBridge Q1: GAAP loss of $0.17/share; FY2024 revenue guidance lowered
Total revenue $83.2M (-3.5% YoY); RCM revenue grew to $53.0M (63.7% of total).
TruBridge amends poison pill, raises triggering threshold to 15% from 10% after stockholder input
Board approved amendment to Rights Plan increasing beneficial ownership threshold from 10% to 15%.
CPSI posts Q4 GAAP loss of $(2.92)/share; amends credit agreement to waive covenant breach
Q4 2023 revenue $85.9M (+3.2% YoY); GAAP loss per share $(2.92), non-GAAP EPS $0.36; adj. EBITDA $12.0M (down 9% YoY).
CPSI divests American HealthTech to PointClickCare for $25M; net cash ~$21.41M
Divested American HealthTech to PointClickCare for $25M base; net cash payout ~$21.41M after escrows and working capital adjustments. Closed Jan 16, 2024.
CFO Chambless departs Dec 31; enters $183.22/hr consulting through Mar 2024
Matthew J. Chambless resigned as CFO, Treasurer and Secretary effective Dec 31, 2023.
CPSI Q3 misses: GAAP loss $(0.24)/sh; cuts FY revenue guidance to $337-342M
Total revenue $82.7M flat YoY; bookings $16.2M down 21% from $20.5M.
CPSI acquires Viewgol for $36M cash plus up to $31.5M earnout
Purchase price $36M cash; earnouts up to $21.5M for 2024 EBITDA ≥$6M and up to $10M for offshore hires in India.
CPSI reports Q2 net loss, lowers adjusted EBITDA guidance to $52.5-54.5M
GAAP net loss of $2.8M ($0.20 loss per diluted share); non-GAAP net income of $5.7M ($0.40 EPS).
CPSI Q1 2023 revenue $86.2M (+11% YoY); GAAP EPS $0.21; RCM revenue up 20%
Total revenue $86.2M, up 11% YoY; GAAP net income $3.1M ($0.21 diluted EPS).
CPSI Q4 revenue $83.2M, non-GAAP EPS $0.61; FY 2023 guidance $340-350M
Q4 2022 revenue $83.2M (+12% YoY); GAAP net income $2.5M ($0.17 diluted EPS); non-GAAP EPS $0.61.
CPSI Q3 revenue $82.8M (+18% YoY); GAAP EPS $0.15 down from $0.19, non-GAAP EPS $0.57
Q3 revenue $82.8M (+18% YoY); GAAP net income $2.2M ($0.15 diluted EPS) vs $2.7M ($0.19) YoY.
CPSI Q2 revenue up 21% to $82.7M; GAAP EPS $0.21 vs $0.42 YoY; non-GAAP EPS $0.59
Revenue $82.7M (+21% YoY); GAAP net income $3.1M ($0.21 diluted EPS) vs $6.1M ($0.42) prior year.
the directors of Merger Sub immediately prior to the Effective Time, Joseph Bernardello, Peter Limeri and Taylor Curtis, became the directors of the Surviving Corporation.
the directors of Merger Sub immediately prior to the Effective Time, Joseph Bernardello, Peter Limeri and Taylor Curtis, became the directors of the Surviving Corporation.
the directors of Merger Sub immediately prior to the Effective Time, Joseph Bernardello, Peter Limeri and Taylor Curtis, became the directors of the Surviving Corporation.
On November 7, 2024, TruBridge, Inc. (the “Company”) announced that David A. Dye will no longer serve as the Company’s Chief Operating Officer, effective December 31, 2024.
On November 1, 2024, TruBridge, Inc. (the “Company”) and David A. Dye, the Company’s Chief Operating Officer and a director of the Company, agreed that Mr. Dye will no longer serve as the Company’s Chief Operating Officer, effective December 31, 2024.
On October 18, 2024, Denise W. Warren submitted her resignation from the Board of Directors (the “Board”) of TruBridge, Inc. (the “Company”), effective November 15, 2024.
Also on October 18, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board elected Amy O’Keefe, effective immediately, to fill the seat on the Board that will be vacated by Ms. Warren.
On March 27, 2024, TruBridge, Inc. (the “Company”) appointed Vita MacIntyre to serve as the Controller of the Company.
On February 5, 2024, after nearly 20 years of service, Charles P. Huffman informed the Board of Directors (the “Board”) of Computer Programs and Systems, Inc. (the “Company”) of his intention to step down from the Board, effective as of the Company’s 2024 Annual Meeting of Stockholders, which is expected to be held in May 2024.
On November 7, 2023, Computer Programs & Systems, Inc. (the “Company”) announced that Matthew J. Chambless will no longer serve as the Company’s Chief Financial Officer, Treasurer and Secretary, effective December 31, 2023.
On November 7, 2023, the Company announced that Vinay Bassi would succeed Mr. Chambless as Chief Financial Officer, Treasurer and Secretary of the Company, effective as of the Effective Date.
On November 1, 2023, Computer Programs & Systems, Inc. (“CPSI” or the “Company”) and Matthew J. Chambless, the Company’s Chief Financial Officer, Treasurer and Secretary, agreed that Mr. Chambless will no longer serve as the Company’s Chief Financial Officer, Treasurer and Secretary, effective December 31, 2023.
Max materiality 1.00 · Median 0.62 · Most common event earnings